Kyndryl Faces Class Action Over Disclosure of Internal Control Deficiencies

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Kyndryl faces class action lawsuit alleging material misrepresentations about financial condition and internal controls. Stock fell 55% after disclosures of control weaknesses and executive departures.

Kyndryl Faces Class Action Over Disclosure of Internal Control Deficiencies

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against Kyndryl Holdings, Inc., alleging the company made material misrepresentations regarding its financial condition and internal control systems. The suit covers the period from August 7, 2024, through February 9, 2026, and was initiated following a series of significant corporate disclosures that prompted substantial shareholder losses.

The legal action was triggered by several adverse developments at the information technology infrastructure company. Kyndryl announced it would be unable to file its quarterly report on a timely basis, disclosed material weaknesses in its internal controls, and announced the departure of three senior executives: its Chief Financial Officer, General Counsel, and Global Controller. These announcements precipitated a notable decline in the company's market valuation.

Following the disclosures, Kyndryl's stock price experienced a sharp decline of approximately 55 percent. The lawsuit seeks to recover damages on behalf of investors who purchased company securities during the specified period. Investors with substantial losses in Kyndryl holdings may be eligible to serve as lead plaintiffs in the litigation.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 28

Related Coverage

GlobeNewswire Inc.

FSK Securities Fraud Lawsuit: Investors Sought for Class Action Over Misleading Statements

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

FSK
GlobeNewswire Inc.

Securities Fraud Investigations Target LKQ, Molina, MongoDB, and Power Solutions

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

MOHLKQMDB
GlobeNewswire Inc.

Upstart Investors Face June 2026 Deadline in Securities Class Action Over Faulty AI Model

Law firm Kirby McInerney LLP reminds Upstart investors of June 8, 2026 deadline to join securities lawsuit alleging the company's Model 22 AI overstated accuracy and loan approvals.

UPST
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF
GlobeNewswire Inc.

CCRN Under Investigation for Alleged Securities Violations

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

CCRN